Crescita Therapeutics (TSE:CTX) Shares Down 1.7% – Here’s Why

Crescita Therapeutics Inc. (TSE:CTX)’s stock price was down 1.7% during mid-day trading on Friday . The stock traded as low as C$0.58 and last traded at C$0.58. Approximately 5,200 shares changed hands during trading, a decline of 77% from the average daily volume of 22,956 shares. The stock had previously closed at C$0.59.

Crescita Therapeutics Stock Performance

The firm has a fifty day simple moving average of C$0.61 and a 200-day simple moving average of C$0.54. The company has a current ratio of 3.37, a quick ratio of 2.29 and a debt-to-equity ratio of 6.02. The stock has a market cap of C$11.24 million, a price-to-earnings ratio of -3.87 and a beta of 1.69.

Crescita Therapeutics Company Profile

Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.